Most Recent
IVF provider Virtus Health would be “the author of its own fate” if its proposed acquisition of rival Adora Fertility flopped, a judge has said in hearing the ACCC’s bid for a temporary injunction blocking completion of the planned purchase.
Software company DST Bluedoor has lost its bid to access communications between its former founding director and AMP in a $35.5 million lawsuit accusing the financial services company of inducing 11 DST employees to jump ship after licensing its online platform.
The ACCC has won an interim injunction blocking IVF provider Virtus Health from completing its purchase of rival Adora Fertility on Friday.
Botox drug maker Allergan has secured an injunction against a Sydney-based cosmetics company which sought to “leverage” the reputation of the well-known injectable to sell its Freezeframe line of anti-aging topical creams.
Five enforcement officers of the Australian Competition and Consumer Commission will be cross-examined by lawyers for banks facing price fixing charges over their conduct following ANZ's $2.5 billion capital raising six years ago.
A judge overseeing a cartel case over a $2.5 billion ANZ share placement has granted ANZ's bid for unredacted documents which the bank says will support its claims that the case should be permanently stayed because of improper dealings between whistleblower JPMorgan, ASIC and the ACCC.
IOOF unit RI Advice has lost its bid to strike out ASIC’s novel case claiming it failed to protect its clients against cybersecurity risks, but a judge has chastised the regulator for causing “needless confusion” and “wasted time”.
A law firm representing a property developer in an investigation of a potential class action against failed asset manager Blue Sky Alternative Investments is seeking access to the firm's insurance documents to decide whether it is "worthwhile" to launch proceedings.
As Australia’s largest cities prepare to emerge from lockdown, law firms are doubling down on their efforts to vaccinate staff, with some going so far as to implement a ‘no jab, no office’ policy.
A judge hearing a price-fixing case against steel giant BlueScope has overruled an objection to the ACCCs barrister's allegedly excessive "eye-rolling" and "scathing and sarcastic" manner during a cross-examination in which the company's general manager was accused of lying under oath.